Immunology of xenotransplantation.
The transplantation of tissues and organs between individuals of different species, that is, xenotransplantation, engenders a variety of immune responses. Xenogeneic immune responses mediated by naturally-occurring antibodies and complement lead to hyperacute and acute vascular rejection of vascularized organ grafts and may also cause vascular rejection of cell and tissue grafts. Under some circumstances, however, a vascularized organ graft may evade humoral rejection despite the presence of anti-donor antibodies in the circulation of the recipient; this condition is called accommodation. Xenogeneic immune responses mediated by T lymphocytes and natural killer cells may cause acute cellular rejection. The extent to which cellular rejection of xenografts resembles cellular rejection of allografts remains to be determined. New insights into the molecular mechanisms underlying the immune responses to xenotransplantation has shed light on the pathogenesis of immunological disease and has allowed the development of specific immunomodulatory strategies that may facilitate clinical application of xenotransplantation.
Saadi
S
S
Department of Surgery, Duke University Durham, North Carolina 27710, USA.
Platt
J L
JL
D000818:Animals; D000937:Antigen-Antibody Reactions; D003167:Complement Activation; D003165:Complement System Proteins / Q000502:physiology; D006084:Graft Rejection; D006085:Graft Survival / Q000276:immunology; D006133:Growth Substances / Q000502:physiology; D006497:Heparan Sulfate / Q000502:physiology; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D018919:Neovascularization, Physiologic; D015427:Reperfusion Injury / Q000503:physiopathology; D013045:Species Specificity; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*
D003165:Complement System Proteins; D006133:Growth Substances; D006497:Heparan Sulfate